Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Injector, Prefilled Pen, Vial (Syringe), Pump, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

  • Published On : Jul 2019 |
  • Pages : 237 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Subcutaneous Drug Delivery Market – Market Insights

Subcutaneous drug delivery route has emerged as a promising and viable alternative to intravenous administration. The demand for subcutaneous delivery route is attributed to the rapid development of biologics in fastest growing sector of the pharmaceutical industry. Moreover, the subcutaneous route of administration is generally preferred, as it enables self-medication, improves quality of life, and thus reduce health care costs.

Furthermore, convenience and safety for both patients and medical professionals offered by subcutaneous devices are major factors leading to growth of the global subcutaneous drug delivery market. According to World Health Organization, 2014, around 2 million healthcare professionals suffered from infectious diseases as result of needlestick injuries globally. The retractable nature of prefilled syringes help to overcome this problem acting as an ideal device to reduce the occurrence of needlestick injuries.

The global subcutaneous drug delivery market size was valued at US$ 7,077.5 million in 2017 and is expected to exhibit a CAGR of 9.5% over the forecast period (2018–2026).

Figure 1. Global Subcutaneous Drug Delivery Market Value (US$ Mn), by Region, 2018

Subcutaneous Drug Delivery  | Coherent Market Insights

                                                                 Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of arthritis, multiple sclerosis, and diabetes to propel the global subcutaneous drug delivery market growth.

Increasing prevalence of multiple sclerosis (MS), rheumatoid arthritis, diabetes, and food allergies is expected to drive growth of the global subcutaneous drug delivery market, as most of the drugs are administered through subcutaneous drug delivery route. According to the study by National Multiple Sclerosis Society, 2017, an estimated 1 million people in the U.S. are living with MS, where around 200 new cases are diagnosed each week in the U.S.

According to the Multiple Sclerosis Trust, 2018, an estimated 2,500,000 people in the world have multiple sclerosis. According to the Arthritis Foundation, 2017, around 41 people were diagnosed with Rheumatoid arthritis (RA) out of every 100,000 people in the U.S. The foundation further states that about 1.3 million Americans have RA.

According to the Indian Diabetes Research Foundation, 2016, around 60% of the world’s population suffering from diabetes lives in Asia, with around one-half in China and India combined. The foundation also states that Western Pacific reported over 138.2 million people suffering from diabetes in 2015, the number for which is expected to rise to 201.8 million by 2035.

According to the World Health Organization (WHO), around 200 to 250 million people suffered from food allergies worldwide in 2015. Moreover, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children.

However, the unavailability of approved products due to increasing number of product recalls by various developers is a factor hindering growth of the global subcutaneous drug delivery market. In 2015, Sanofi US voluntarily recalled Auvi-Q (epinephrine injection, USP) including both 0.15 mg and 0.3 mg strengths from hospitals, retailers, and consumers, as the products had inaccurate dosage delivery, resulting in failure to provide intended drug dose.

Figure 2. Global Subcutaneous Drug Delivery Market Share (%), by Disease Indication

           Subcutaneous Drug Delivery  | Coherent Market Insights

                                                                     Source: Coherent Market Insights Analysis (2019)

Prevention of needlestick injuries to bolster the market growth.

Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the global subcutaneous drug delivery market. According to the Health Protection Agency (HPA) report, in 2012, injuries among medical and dental professionals while treating patients increased by 131% (100-231) from 2002 to 2011.

Moreover, preference for safety injection devices is increasing among healthcare professionals and manufacturers, as these devices decrease chances of needlestick injuries. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Moreover, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries.

Key Players

Major players operating in the global subcutaneous drug delivery market include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.

The market comprises of products, which are available in reusable and disposable form. Disposable segment is expected to witness growth, owing to significant increase in self-administration of drugs to treat chronic diseases. Moreover, the shift from vial-and-syringe format, which is prone to dosing errors and low patient-compliance rates to prefilled syringes that enable the use of disposable and single-use syringes already filled with a prescribed unit dose of medication, is expected to enhance the market growth.

Market Dynamics

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, higher cost of auto-injectors and product recalls are factors expected to restrain the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global subcutaneous drug delivery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market

Detailed Segmentation:

  • Global Subcutaneous Drug Delivery Market, By Usability:
    • Disposable
    • Reusable
  • Global Subcutaneous Drug Delivery Market, By Disease Indication:
    • Auto-immune Disorders
    • Neurological Disorders
    • Oncology Disorders
    • Hormonal Disorders
    • Allergy & Infectious Disorders
    • Ophthalmic Disorders
    • Others
  • Global Subcutaneous Drug Delivery Market, By Delivery Type:
    • Prefilled Syringe
    • Injector
    • Prefilled Pen
    • Vial (Syringe)
    • Pump and Others
  • Global Subcutaneous Drug Delivery Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Subcutaneous Drug Delivery Market, By Region:
    • North America
      • By Usability:
        • Disposable
        • Reusable
      • By Disease Indication:
        • Auto-immune Disorders
        • Neurological Disorders
        • Oncology Disorders
        • Hormonal Disorders
        • Allergy & Infectious Disorders
        • Ophthalmic Disorders
        • Others
      • By Delivery Type:
        • Prefilled Syringe
        • Injector
        • Prefilled Pen
        • Vial (Syringe)
        • Pump and Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Usability:
        • Disposable
        • Reusable
      • By Disease Indication:
        • Auto-immune Disorders
        • Neurological Disorders
        • Oncology Disorders
        • Hormonal Disorders
        • Allergy & Infectious Disorders
        • Ophthalmic Disorders
        • Others
      • By Delivery Type:
        • Prefilled Syringe
        • Injector
        • Prefilled Pen
        • Vial (Syringe)
        • Pump and Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Usability:
        • Disposable
        • Reusable
      • By Disease Indication:
        • Auto-immune Disorders
        • Neurological Disorders
        • Oncology Disorders
        • Hormonal Disorders
        • Allergy & Infectious Disorders
        • Ophthalmic Disorders
        • Others
      • By Delivery Type:
        • Prefilled Syringe
        • Injector
        • Prefilled Pen
        • Vial (Syringe)
        • Pump and Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Usability:
        • Disposable
        • Reusable
      • By Disease Indication:
        • Auto-immune Disorders
        • Neurological Disorders
        • Oncology Disorders
        • Hormonal Disorders
        • Allergy & Infectious Disorders
        • Ophthalmic Disorders
        • Others
      • By Delivery Type:
        • Prefilled Syringe
        • Injector
        • Prefilled Pen
        • Vial (Syringe)
        • Pump and Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Usability:
        • Disposable
        • Reusable
      • By Disease Indication:
        • Auto-immune Disorders
        • Neurological Disorders
        • Oncology Disorders
        • Hormonal Disorders
        • Allergy & Infectious Disorders
        • Ophthalmic Disorders
        • Others
      • By Delivery Type:
        • Prefilled Syringe
        • Injector
        • Prefilled Pen
        • Vial (Syringe)
        • Pump and Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Usability:
        • Disposable
        • Reusable
      • By Disease Indication:
        • Auto-immune Disorders
        • Neurological Disorders
        • Oncology Disorders
        • Hormonal Disorders
        • Allergy & Infectious Disorders
        • Ophthalmic Disorders
        • Others
      • By Delivery Type:
        • Prefilled Syringe
        • Injector
        • Prefilled Pen
        • Vial (Syringe)
        • Pump and Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novo Nordisk A/S
    • Johnson & Johnson
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • F. Hoffmann-La Roche AG
    • Consort Medical plc
    • Eli Lilly and Company
    • Merck & Co., Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Usability
      • Market Snippet, By Disease Indication
      • Market Snippet, By Delivery Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Reimbursement Scenario
    • Merger and Acquisition Scenario
    • PEST Analysis
    • Epidemiology
  4. Global Subcutaneous Drug Delivery Market, By Usability, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Disposable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Reusable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Subcutaneous Drug Delivery Market, By Disease Indication, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Auto-immune Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Neurological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Oncology Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Hormonal Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Allergy & Infectious Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Ophthalmic Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Subcutaneous Drug Delivery Market, By Delivery System, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Prefilled Syringe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Injector
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Prefilled Pen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Vial (Syringe)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Pump and Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global Subcutaneous Drug Delivery Market, By Region, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Becton Dickinson and Company*
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novo Nordisk A/S
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Amgen, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Consort Medical plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 36 market data tables and 30 figures on "Subcutaneous Drug Delivery Market” - Global forecast to 2026.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.